Treace Medical Concepts, a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty and Adductoplasty Procedures, today announced the successful completion of the first cases utilizing SpeedPlate MicroQuad implants.
The MicroQuad implant expands upon the broad utility of the SpeedPlate platform, which is designed for fast titanium compression fixation. The MicroQuad implant has a unique anatomic design with multiple points of fixation on each side of the joint to deliver dynamic compression with rotational stability through a one-inch incision for compatibility with minimally invasive techniques.
“The MicroQuad implant builds on the success of our proprietary SpeedPlate technology to provide a highly differentiated solution for fast, stable fixation designed to meet the growing surgeon and patient demand for minimally invasive Lapiplasty and Adductoplasty approaches,” said John T. Treace, CEO, Founder and Board Member of Treace. “We look forward to further expanding surgeon access to the MicroQuad implant as we move into full market release within the first half of 2025.”
William T. DeCarbo, DPM, of Greater Pittsburgh Foot & Ankle Center and a member of Treace’s Surgeon Advisory Board, who performed initial cases with the SpeedPlate MicroQuad implant, commented, “The MicroQuad implant takes the SpeedPlate system to a new level with an anatomic contour and additional rotational stability that gives me the clinical confidence I can deliver robust fixation through a small incision that patients desire.”
